ClinicalTrials.gg
Sign In
BiologicalDrug

Natural Killer Cell clinical trials

studies test it
39
open now
10
in phase 3
1
first study started
2005

How each study uses Natural Killer Cell is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Natural Killer Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

NK cells
19
NK Cell Infusion
6
natural killer cell infusion
4
NK cell
3
Natural killer cell
2

In one entry with another drug

Given together, or one or the other

Trastuzumab + NK cells
2

Studies by the year they started

39 studies that test it; most in 2016 (4)

Studies that test Natural Killer Cell, by start year
YearStudies
20051
20062
20071
20082
20091
20132
20142
20152
20164
20173
20183
20191
20202
20212
20221
20231
20242
20254
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
27
Phase 2
16
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Leukemia, Myeloid, Acute
6
Neuroblastoma
3
Lymphoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Renal Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Pancreatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Colorectal Neoplasms
1
Glioblastoma
1
Ganglioneuroblastoma
1

Who runs them

Industry 1 · Other 38

M.D. Anderson Cancer Center (5) · National University Hospital, Singapore (4) · St. Jude Children's Research Hospital (2) · Southwest Hospital, China (2) · Dana-Farber Cancer Institute (1) · New Approaches to Neuroblastoma Therapy Consortium (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Institut Paoli-Calmettes (1)

Often tested with

Tested in the same studies.

Interleukin-2 (4) · Dinutuximab (3) · Granulocyte-Macrophage Colony-Stimulating Factor (2) · Cetuximab (2) · Trastuzumab (2) · Lenalidomide (1) · Bortezomib (1) · Anti-GD2 Monoclonal Antibody hu14.18K322A (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6, 1 in phase 3

Studies that test Natural Killer Cell, phase 3 first.

Studies

Open first, then newest update. How each study uses Natural Killer Cell is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test Natural Killer Cell →

Given beside what is tested · 11 — Natural Killer Cell is usual care or a partner of the new treatment